Évaluation de l'impact socioéconomique potentiel de la médecine personnalisée
Since 2000, Québec and Canada have made significant R&D investments in the area of genomics, with a particular focus on technological platform development and genetics.
[ - ]
To justify these and future major investments in genomic research, clear benefits of genomic technologies to society must be demonstrated.
The goals of the study are to provide methodology to evaluate potential socio-economic impact of personalized medicines, to demonstrate it on two applications of genomic technology and to summarize obstacles to realize the potential socio-economic benefits of genomic research.
The following report is the presentation of the project made at Genome Quebec.
